Stocks
Blueprint Medicines Corporation (BPMC) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -9.49 | 15.1 | -8.51 | -3.45 | -11.9 | -14.6 | ||
| Changes by years, y/y, % | +19% | -259% | -156% | -59% | +245% | +8.4% | |||
Blueprint Medicines Corporation. EV/EBITDA
Blueprint Medicines Corporation. EV/EBITDA, changes, %
Blueprint Medicines Corporation (BPMC) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -4.55 | -12.1 | -13.8 | -20.9 | -23.3 | -14.6 | |
| Changes by years, y/y, % | +4% | +260% | +308% | +253% | +412% | |||
| Changes by quarters, q/q, % | -23% | +166% | +14% | +52% | +11% | |||
